Seroprevalence of Toxoplasma gondii in patients receiving cancer treatment

Journal Title: Cumhuriyet Medical Journal - Year 2018, Vol 40, Issue 1

Abstract

Objective: Toxoplasma gondii (T. gondii) is a protozoon infecting many living species in the world and causing clinical pictures that can end with death in humans, especially in patients with blunted immune system. Chemotherapy and radiotherapy administrations in cancer patients cause the reactivation of latent T. gondii by impairing both cellular and humoral immune system. The purpose of this study is to determine the seroprevalence of T. gondii in patients who have applied to and received cancer treatment in the Health Services Research and Application Hospital of Cumhuriyet University in Sivas Method: The study was conducted on the patients aged between 18-80, who applied to the Radiation Oncology Polyclinic in the Health Services Research and Application Hospital of Cumhuriyet University and the sample consisted of 100 cancer patients receiving chemotherapy and 100 healthy people in the control group. Toxoplasma IgG and IgM antibodies were analyzed with the ELISA method in the blood samples taken from this peoples. Results: In our study, Toxoplasma IgG positivity was determined in 60 (60.0%) of the 100 cancer patients receiving chemotherapy in the Health Services Research and Application Hospital of Cumhuriyet University and 27 (27.0%) of the control group. The difference between the groups was found to be significant. Cancer patients included in the study consisted of especially lung cancer, breast cancer, stomach cancer, colon cancer and ovarian cancer patients. IgM positivity (1.0%) was determined in one individual in both the cancer patients and the control group, and the difference between the groups was found to be insignificant. Conclusions: Opportunistic infections like toxoplasmosis are more frequent in cancer patients with the blunted immune system compared to individuals with the normal immune systems. These individuals are more prone to infections and the risk of the reactivation of toxoplasmosis experienced before is higher in these patients. Therefore, it will be appropriate for these patients to be periodically evaluated in terms of Toxoplasma.

Authors and Affiliations

Mehtap Alim, Semra Özçelik, Necati Özpınar

Keywords

Related Articles

Biphasic malignant mesothelioma of the testis: Case report

Malign Mesothelioma is a tumor originating from serous lining. Although it was most commonly seen in pleura, it can also located in other areas such as peritoneal and rarely paratesticular region. Our case presented with...

Assessment of the nurses' work environment using the nursing work index scale

Objective: One of the major reasons for the increase in nurse turnover rate in hospitals is the nurses’ negative work environment. The negativity of the work environment reduces nurses’ performance and adversely affects...

Assessment of the relationship between intraabdominal fat thickness and the aortomesenteric angle and distance using computed tomography

Objective: The aim of this study is to evaluate the effect of visceral fat thickness on the distance and angle between the superior mesenteric artery (SMA) and the aorta in the normal population. Method: The aortomesente...

A novel radiological proximal femoral angles facilitate peritrochanteric surgery

Objective: The geometry of the proximal femur has gained very much attention in the last decade. Many radiological measures have been introduced to help radiologists and orthopaedic surgeons to evaluate surgeries, diagno...

A case with acute idiopathic blue finger

A case with acute idiopathic blue finger

Download PDF file
  • EP ID EP272018
  • DOI 10.7197/223.vi.387046
  • Views 106
  • Downloads 0

How To Cite

Mehtap Alim, Semra Özçelik, Necati Özpınar (2018). Seroprevalence of Toxoplasma gondii in patients receiving cancer treatment. Cumhuriyet Medical Journal, 40(1), 731-736. https://europub.co.uk/articles/-A-272018